GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Cryostem Corp (OTCPK:CRYO) » Definitions » Equity-to-Asset

American Cryostem (American Cryostem) Equity-to-Asset : -1.77 (As of Jun. 2022)


View and export this data going back to 2010. Start your Free Trial

What is American Cryostem Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. American Cryostem's Total Stockholders Equity for the quarter that ended in Jun. 2022 was $-1.88 Mil. American Cryostem's Total Assets for the quarter that ended in Jun. 2022 was $1.06 Mil. Therefore, American Cryostem's Equity to Asset Ratio for the quarter that ended in Jun. 2022 was -1.77.

The historical rank and industry rank for American Cryostem's Equity-to-Asset or its related term are showing as below:

CRYO's Equity-to-Asset is not ranked *
in the Biotechnology industry.
Industry Median: 0.66
* Ranked among companies with meaningful Equity-to-Asset only.

American Cryostem Equity-to-Asset Historical Data

The historical data trend for American Cryostem's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Cryostem Equity-to-Asset Chart

American Cryostem Annual Data
Trend Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.01 -0.55 -0.96 -0.29 -1.75

American Cryostem Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.35 -1.75 -1.25 -1.59 -1.77

Competitive Comparison of American Cryostem's Equity-to-Asset

For the Biotechnology subindustry, American Cryostem's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Cryostem's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Cryostem's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where American Cryostem's Equity-to-Asset falls into.



American Cryostem Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

American Cryostem's Equity to Asset Ratio for the fiscal year that ended in Sep. 2021 is calculated as

Equity to Asset (A: Sep. 2021 )=Total Stockholders Equity/Total Assets
=-1.848/1.056
=-1.75

American Cryostem's Equity to Asset Ratio for the quarter that ended in Jun. 2022 is calculated as

Equity to Asset (Q: Jun. 2022 )=Total Stockholders Equity/Total Assets
=-1.876/1.058
=-1.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


American Cryostem  (OTCPK:CRYO) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


American Cryostem Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of American Cryostem's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


American Cryostem (American Cryostem) Business Description

Traded in Other Exchanges
N/A
Address
1 Meridian Road, Suite 5, Eatontown, NJ, USA, 07724
American Cryostem Corp is a biotechnology company which standardizes adipose tissue-derived technologies (Adult Stem Cells) for the fields of Regenerative and Personalized Medicine. The company acts as an innovator of adipose tissue and stem cell platform technologies. It provides the clinical grade, adipose tissue and adult stem cell collection, processing, and cryo-preservation technology, providing first-in-class cellular therapy products and services for patients, physicians and researchers based on the transformative science of Regenerative and Personalized Medicine.
Executives
John S Arnone director, officer: Chairman 111 GREAT NECK RD, GREAT NECK NY 11021
Anthony Francis Dudzinski director, officer: COO 188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Acs Global, Inc. 10 percent owner 188 E. BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Christopher Joseph Neill 10 percent owner 188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Hector Medina director, 10 percent owner, officer: President and Director 1206 STAGECOACH TRAIL LOOP, CHULA VISTA CA 91915